Andersons pediatric cardiology 1579

7.GillettePC,NihillMR,SingerDB.
Electrophysiologicalmechanismfortheshort
PRintervalinPompe'sdisease.AmJDisChild.
1974;128:622–626.
8.BuckleyBH,HutchinsGM.Pompe'sdisease
presentingashypertrophiccardiomyopathywith
Wolff–parkinson–whitesyndrome.AmHeartJ.
1978;96:246–252.
9.KishnaniPS,CorzoD,NicolinoM,etal.
Recombinanthumanacid[alpha]-glucosidase:
majorclinicalbenefitsininfantile-onsetpompe
disease.Neurology.2007;68(2):99–109.
10.ChienYH,LeeNC,ThurbergBL,etal.Pompe
diseaseininfants:improvingtheprognosisby
newbornscreeningndearlytreatment.
Pediatrics.2009;124(6):e1116–e1125.
11.NishinoI.Autophagicvacuolarmyopathy.Semin
PediatrNeurol.2006;13(2):90–95.
12.LabruneP,HuguetP,OdieureM.
Cardiomyopathyinglycogenstoragedisease
typeIII:clinicalandechographicstudyof18
patients.PediatrCardiol.1991;12:161–163.
13.DagliA,SentnerCP,WeinsteinDA,etal.
GlycogenstoragediseasetypeIII.PagonRA,
AdamMP,ArdingerHH.GeneReviews
[Internet].UniversityofWashington:Seattle
(WA);2010[Seattle;1993-2017;[Updated2016


Dec29].
14.ColemanRA,WinterHS,WolfB,GilchristJM,

ChenYT.GlycogenstoragediseasetypeIII
(glycogendebranchingenzymedeficiency):
correlationofbiochemicaldefectswith
myopathyandcardiomyopathy.AnnInternMed.
1992;116(11):896–900.
15.SentnerCP,HoogeveenIJ,WeinsteinDA,etal.
GlycogenstoragediseasetypeIII:diagnosis,
genotype,management,clinicalcourseand
outcome.JInheritMetabDis.2016;39(5):697–
704.
16.CarvalhoJS,MatthewsEE,LeonardJV,
DeanfieldJ.Cardiomyopathyofglycogen
storagediseasetypeIII.HeartVessels.
1993;8(3):155–159.
17.LeePJ,DeanfieldJE,BurchM,etal.
Comparisonofthefunctionalsignificanceofleft
ventricularhypertrophyinhypertrophic
cardiomyopathyandglycogenosistypeIII.AmJ
Cardiol.1997;79(6):834–838.
18.ServideiS,RiepeRE,LangstonC,etal.Severe
cardiopathyinbranchingenzymedeficiency.J
Pediatr.1987;111(1):51–56.
19.TangTT,SeguraAD,ChenYT,etal.Neonatal
hypotoniaandcardiomyopathysecondaryto
typeIVglycogenosis.ActaNeuropathol(Berl).


1994;87(5):531–536.
20.NaseS,KunzeKP,SigmundM,etal.Anew
variantoftypeIVglycogenosiswithprimary

cardiacmanifestationandcompletebranching
enzymedeficiency.Invivodetectionbyheart
musclebiopsy.EurHeartJ.1995;16(11):1698–
1704.
21.MagoulasPL,El-HattabAW.Glycogenstorage
diseasetypeIV.PagonRA,AdamMP,Ardinger
HH,etal.GeneReviews.Universityof
Washington,:Seattle(WA);2013[Seattle;19932017].
22.ScalcoRS,MorrowJM,BoothS,etal.
Misdiagnosisisanimportantfactorfor
diagnosticdelayinMcArdledisease.
NeuromusculDisord.2017[pii:S09608966(17)30056-1].
23.MilsteinJM,HerronTM,HaasJE.Fatalinfantile
musclephosphorylasedeificiency.JChild
Neurol.1989;4(3):186–188.
24.MirandaAF,NetteEG,HartlagePL,DiMauroS.
Phosphorylaseisoenzymesinnormaland
myophosphorylase-deficienthumanheart.
Neurology.1979;29(11):1538–1541.
25.SalterRH.Themuscleglycogenoses.Lancet.
1968;1:1301–1304.
26.ServideiS,MetlayLA,ChodoshJ,DiMavroS.